Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CCR5 status and metastatic progression in colorectal cancer.
Suarez-Carmona M, Chaorentong P, Kather JN, Rothenheber R, Ahmed A, Berthel A, Heinzelmann A, Moraleda R, Valous NA, Kosaloglu Z, Eurich R, Wolf J, Grauling-Halama S, Hundemer M, Lasitschka F, Klupp F, Kahlert C, Ulrich A, Schneider M, Falk C, Jäger D, Zoernig I, Halama N. Suarez-Carmona M, et al. Among authors: jager d. Oncoimmunology. 2019 Jul 13;8(9):e1626193. doi: 10.1080/2162402X.2019.1626193. eCollection 2019. Oncoimmunology. 2019. PMID: 31428524 Free PMC article.
Robust gridding of TMAs after whole-slide imaging using template matching.
Lahrmann B, Halama N, Westphal K, Ernst C, Elsawaf Z, Sinn P, Bosch FX, Dickhaus H, Jäger D, Schirmacher P, Grabe N. Lahrmann B, et al. Among authors: jager d. Cytometry A. 2010 Dec;77(12):1169-76. doi: 10.1002/cyto.a.20949. Cytometry A. 2010. PMID: 20662092 Free article.
Predictive immunological markers in oncology.
Jäger D, Seil I, Halama N. Jäger D, et al. Front Immunol. 2012 Jan 6;2:86. doi: 10.3389/fimmu.2011.00086. eCollection 2011. Front Immunol. 2012. PMID: 22566875 Free PMC article. No abstract available.
Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.
Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L, Klapproth K, Schäkel K, Garbi N, Jäger D, Weitz J, Schmitz-Winnenthal H, Hämmerling GJ, Beckhove P. Klug F, et al. Among authors: jager d. Cancer Cell. 2013 Nov 11;24(5):589-602. doi: 10.1016/j.ccr.2013.09.014. Epub 2013 Oct 24. Cancer Cell. 2013. PMID: 24209604 Free article.
570 results